Literature DB >> 18688041

Dysfunctional glycogen storage in a mouse model of alpha1-antitrypsin deficiency.

Ralf H Hubner1, Philip L Leopold, Maija Kiuru, Bishnu P De, Anja Krause, Ronald G Crystal.   

Abstract

Autophagy is an intracellular pathway that contributes to the degradation and recycling of unfolded proteins. Based on the knowledge that autophagy affects glycogen metabolism and that alpha(1)-antitrypsin (AAT) deficiency is associated with an autophagic response in the liver, we hypothesized that the conformational abnormalities of the Z-AAT protein interfere with hepatocyte glycogen storage and/or metabolism. Compared with wild-type mice (WT), the Z-AAT mice had lower liver glycogen stores (P < 0.001) and abnormal activities of glycogen-related enzymes, including acid alpha-glucosidase (P < 0.05) and the total glycogen synthase (P < 0.05). As metabolic consequences, PiZ mice demonstrated lower blood glucose levels (P < 0.05), lower body weights (P < 0.001), and lower fat pad weights (P < 0.001) compared with WT. After the stress of fasting or partial hepatectomy, PiZ mice had further reduced liver glycogen and lower blood glucose levels (both P < 0.05 compared WT). Finally, PiZ mice exhibited decreased survival after partial hepatectomy (P < 0.01 compared with WT), but this was normalized with postoperative dextrose supplementation. In conclusion, these observations are consistent with the general concept that abnormal protein conformation and degradation affects other cellular functions, suggesting that diseases in the liver might benefit from metabolic compensation if glycogen metabolism is affected.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688041      PMCID: PMC2633144          DOI: 10.1165/rcmb.2008-0029OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  44 in total

1.  Caveolin-1 is essential for liver regeneration.

Authors:  Manuel A Fernández; Cecilia Albor; Mercedes Ingelmo-Torres; Susan J Nixon; Charles Ferguson; Teymuras Kurzchalia; Francesc Tebar; Carlos Enrich; Robert G Parton; Albert Pol
Journal:  Science       Date:  2006-09-15       Impact factor: 47.728

2.  Intracellular inclusions containing mutant alpha1-antitrypsin Z are propagated in the absence of autophagic activity.

Authors:  Takahiro Kamimoto; Shisako Shoji; Tunda Hidvegi; Noboru Mizushima; Kyohei Umebayashi; David H Perlmutter; Tamotsu Yoshimori
Journal:  J Biol Chem       Date:  2005-12-19       Impact factor: 5.157

Review 3.  The role of autophagy in alpha-1-antitrypsin deficiency: a specific cellular response in genetic diseases associated with aggregation-prone proteins.

Authors:  David H Perlmutter
Journal:  Autophagy       Date:  2006-10-05       Impact factor: 16.016

4.  Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice.

Authors:  J A Carlson; B B Rogers; R N Sifers; M J Finegold; S M Clift; F J DeMayo; D W Bullock; S L Woo
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

5.  Retention of mutant alpha(1)-antitrypsin Z in endoplasmic reticulum is associated with an autophagic response.

Authors:  J H Teckman; D H Perlmutter
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-11       Impact factor: 4.052

6.  Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease.

Authors:  A G Bijvoet; E H van de Kamp; M A Kroos; J H Ding; B Z Yang; P Visser; C E Bakker; M P Verbeet; B A Oostra; A J Reuser; A T van der Ploeg
Journal:  Hum Mol Genet       Date:  1998-01       Impact factor: 6.150

7.  Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency.

Authors:  J A Burrows; L K Willis; D H Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

8.  Vinblastine-induced autophagocytosis: effects on liver glycogen.

Authors:  P Hirsimäki
Journal:  FEBS Lett       Date:  1983-01-10       Impact factor: 4.124

9.  A lag in intracellular degradation of mutant alpha 1-antitrypsin correlates with the liver disease phenotype in homozygous PiZZ alpha 1-antitrypsin deficiency.

Authors:  Y Wu; I Whitman; E Molmenti; K Moore; P Hippenmeyer; D H Perlmutter
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

10.  Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency.

Authors:  S Eriksson; J Carlson; R Velez
Journal:  N Engl J Med       Date:  1986-03-20       Impact factor: 91.245

View more
  3 in total

1.  CHOP and c-JUN up-regulate the mutant Z α1-antitrypsin, exacerbating its aggregation and liver proteotoxicity.

Authors:  Sergio Attanasio; Rosa Ferriero; Gwladys Gernoux; Rossella De Cegli; Annamaria Carissimo; Edoardo Nusco; Severo Campione; Jeffrey Teckman; Christian Mueller; Pasquale Piccolo; Nicola Brunetti-Pierri
Journal:  J Biol Chem       Date:  2020-07-28       Impact factor: 5.157

2.  Bile Duct Ligation Induces ATZ Globule Clearance in a Mouse Model of α-1 Antitrypsin Deficiency.

Authors:  Zahida Khan; Shinichiro Yokota; Yoshihiro Ono; Aaron W Bell; Michael Oertel; Donna B Stolz; George K Michalopoulos
Journal:  Gene Expr       Date:  2016-08-18

3.  MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.

Authors:  Shu-Hong Chen; Xiao-Nan Liu; Yan Peng
Journal:  J Cell Mol Med       Date:  2019-07-09       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.